| | | | |
CUSIP No. 52110H 100 | | 13D/A | | Page 7 of 8 |
Explanatory Note: This Amendment No. 17 (this “Amendment”) to the Schedule 13D (the “Initial 13D”) filed by the Reporting Persons (as defined below) with the U.S. Securities and Exchange Commission (the “Commission”) on March 26, 2018, relating to Common Stock of Lazydays Holdings, Inc. (the “Issuer”) (formerly known as Andina II Holdco Corp.), a Delaware corporation, and as amended and supplemented by Amendment No. 1 to the Initial 13D filed on December 17, 2018, by Amendment No. 2 to the Initial 13D filed on December 18, 2019, by Amendment No. 3 to the Initial 13D filed on May 20, 2020, by Amendment No. 4 to the Initial 13D filed on June 19, 2020, by Amendment No. 5 to the Initial 13D filed on August 5, 2020, by Amendment No. 6 to the Initial 13D filed on October 9, 2020, by Amendment No. 7 to the Initial 13D filed on November 27, 2020, by Amendment No. 8 to the Initial 13D filed on December 10, 2021, by Amendment No. 9 to the Initial 13D filed on December 14, 2021, by Amendment No. 10 to the Initial 13D filed on November 9, 2022, by Amendment No. 11 to the Initial 13D filed on November 14, 2022, by Amendment No. 12 to the Initial 13D filed on December 7, 2022, by Amendment No. 13 to the Initial 13D filed on March 2, 2023, by Amendment No. 14 to the Initial 13D filed on March 7, 2023, by Amendment No. 15 to the Initial 13D filed on March 20, 2023 and by Amendment No. 16 to the Initial 13D filed on May 23, 2023, amends and supplements the items set forth herein.
As used in this statement, the term “Reporting Persons” collectively refers to:
| • | | Coliseum Capital Management, LLC, a Delaware limited liability company (“CCM”); |
| • | | Coliseum Capital, LLC, a Delaware limited liability company (“CC”); |
| • | | Coliseum Capital Partners, L.P., a Delaware limited partnership (“CCP”); |
| • | | Adam Gray (“Gray”); and |
| • | | Christopher Shackelton, a director of the Issuer (“Shackelton”). |
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 is supplemented as follows:
The source and amount of funds used in purchasing the Common Stock described in Item 5(c) by the Reporting Persons and a separate account investment advisory client of CCM (the “Separate Account”) were as follows:
| | | | | | | | |
Purchaser | | Source of Funds | | | Amount | |
CCP | | | Working Capital | | | $ | 1,632,267.65 | |
Separate Account | | | Working Capital | | | $ | 420,724.88 | |
Item 5. Interest in Securities of the Issuer.
Item 5 is hereby amended and supplemented as follows:
| | |
(a)–(b) | | The information relating to the beneficial ownership of Common Stock by each of the Reporting Persons set forth in Rows 7 through 13 of the cover pages hereto is incorporated by reference herein. The percentages set forth in Row 13 for all cover pages filed herewith are calculated based upon 14,028,037 shares of Common Stock outstanding as of November 2, 2023 as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Commission on November 3, 2023. |